Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

NHS England uses £10m fund to retain GPs

May 30, 2018 Medical Communications, Research and Development GP, NHS, UK government, biotech, drugs, pharma, pharmaceutical

On the day that news broke, through Pulse, that over a million patients have had to move GP surgery in …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

May 25, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Cancer, Gielad, Novartis, brexit, obesity, pharma, top ten

It’s a special Firday here in Europe, as today marks the advent of the General Data Protection Regulation (GDPR), an …
News
novato-south-campus

BioMarin receives FDA nod for its would-be blockbuster

May 25, 2018 Medical Communications, Sales and Marketing BioMarin, biotech, drugs, pharma, pharmaceutical

BioMarin is confident that its newly approved treatment for phenylketonuria (PKU) is set to become a blockbuster and it’s priced the …
News

AZ’s Imfinzi hits second major milestone at Phase 3 in unresectable lung cancer

May 25, 2018 Medical Communications, Research and Development AstraZeneca, Imfinzi, NSCLC, lung cancer, pharma

AstraZeneca and its global biologics R&D MedImmune have lifted the curtain on new Phase 3 data for their immunotherapy Imfinzi …
News
breast_cancer_scan

Breast cancer screening scandal potentially involves even more women

May 25, 2018 Medical Communications Jeremy Hunt, NHS, biotech, drugs, pharma, pharmaceutical

The news broke at the start of the month that a number of women who should have been invited to …
News
prothena-37882-2

Prothena guts workforce by more than half, after trial failure

May 25, 2018 Medical Communications Neil Woodford, Prothena, Roche, biotech, drugs, pharma, pharmaceutical

Prothena Therapeutics has acted drastically by slashing staff numbers by more than half, after the failure of two pivotal trials …
News
john_crowley_edit

John Crowley speaks on drug development and the FDA

May 24, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amicus Therapeutics, John Crowley, biotech, drugs, pharma, pharmaceutical

Pharmafocus spoke to John Crowley, CEO of Amicus Therapeutics, about his highly unusual career in the pharmaceutical and biotech industries.
Feature
astellas_tokyo_copy

Astellas begins major restructure, as 600 jobs slashed

May 24, 2018 Medical Communications Astellas, biotech, drugs, pharma, pharmaceutical

Astellas, under the direction of new CEO, Kenji Yasukawa, has unveiled a major new restructure, ahead of a difficult looking …
News
nhs_parliament_2_4

Report calls for tax rises to fund ailing NHS

May 24, 2018 Medical Communications IFS, NHS, UK government, biotech, drugs, pharma, pharmaceutical

A report published by the Institute for Fiscal Studies (IFS) has stressed that UK funding into the NHS needs to …
News

NHS Trust harnesses AI to speed up treatment

May 22, 2018 Manufacturing and Production, Medical Communications AI, NHS, biotech, drugs, pharma, pharmaceutical

The Royal Liverpool and Broadgreen University Hospitals NHS Trust has teamed up with a provider of AI systems to introduce …
News
shutterstock_349943306

Clinical trials, Brexit and the question of ‘full alignment’

May 21, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brexit, clinical trials, feature, pharma

Gene Matthews, Partner at Leigh Day, reviews the tough decisions the UK has to make regarding its position in the …
Feature
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

May 18, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, FDA, Novartis, Takeda, Trump, brexit, pharma, pharmafile, top ten

The year is flying by – it’s another Friday, and that means another Top Ten run-down.Perhaps the biggest story this …
News
ebola

Ebola threat intensifies in DR Congo

May 18, 2018 Medical Communications Ebola, MSD, biotech, drugs, pharma, pharmaceutical

The Ebola outbreak in the Democratic Republic of Congo is becoming increasingly serious, after it was confirmed that there was …
News

Pfizer’s Lyrica achieves endpoint as adjunct in paediatric epilepsy

May 18, 2018 Medical Communications, Research and Development FDA, Lyrica, Pfizer, epilepsy, pharma

Pfizer has revealed new Phase 3 data for its oral epilepsy therapy Lyrica (pregbalin) as an adjunctive treatment for partial …
News
headache

Amgen/Novartis potential blockbuster migraine med gets FDA nod

May 18, 2018 Medical Communications, Sales and Marketing Allergan, Amgen, Novartis, biotech, drugs, migraine, pharma, pharmaceutical

The first in a new class of migraine treatments has just received approval from the FDA; Amgen and Novartis’ Aimovig …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025